Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A high-level view of clinical research activity for Lung Adenocarcinoma in Situ — useful for advocacy organizations, journalists, and researchers. If you’re looking for a trial to join, see the Find a Trial tab.
Lung Adenocarcinoma in Situ has an emerging clinical trial program, driven by procedure and drug treatment.
Recruiting
Active Trials
1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.
1 trials are observational or have no phase designation.
Trials often recruit across multiple countries, so totals exceed the trial count.
Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.
Last sync: June 8, 2026 at 7:20 PM